STOK (STOCKS)
Stoke Therapeutics, Inc. Common Stock
$24.610000
+1.350000 (+5.80%)
Prev close: $23.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ian Frederick Smith
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,588.57M
- Employees
- 128
- P/E (TTM)
- -6.90
- P/B (TTM)
- 4.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.93 | $-0.81 | -0.1188 | -14.65% |
|
Mar 2026 (Q1)
|
$-0.79 | $-0.84 | +0.0535 | +6.34% |
|
Dec 2025 (Q4)
|
$-0.97 | $-0.73 | -0.2421 | -33.26% |
|
Sep 2025 (Q3)
|
$-0.65 | $-0.58 | -0.0703 | -12.13% |